{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:19:20Z","timestamp":1792721960344,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR-CS-2016-16-011"],"award-info":[{"award-number":["NIHR-CS-2016-16-011"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["Senior Investigator Award"],"award-info":[{"award-number":["Senior Investigator Award"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["ACF-2016-17-018"],"award-info":[{"award-number":["ACF-2016-17-018"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2020-2","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T06:16:17Z","timestamp":1523600177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Lymphocyte subset expression and serum concentrations of PD-1\/PD-L1 in sepsis - pilot study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8076-6900","authenticated-orcid":false,"given":"Julie K.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Shankar-Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"issue":"8","key":"2020_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"12","key":"2020_CR2","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13(12):862\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2020_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, Wiewel MA, Davenport EE, Burnham KL, Nurnberg P, Schultz MJ, Horn J, Cremer OL, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. 2017;5(10):816\u201326.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"2020_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17(7):407\u201320.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2020_CR5","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/cc13176","volume":"18","author":"K Chang","year":"2014","unstructured":"Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, Robbins P, Ulbrandt N, Suzich J, Green J, et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care. 2014;18(1):R3.","journal-title":"Crit Care"},{"issue":"6","key":"2020_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1189\/jlb.4HI0616-255R","volume":"100","author":"AC Patera","year":"2016","unstructured":"Patera AC, Drewry AM, Chang K, Beiter ER, Osborne D, Hotchkiss RS. Frontline science: defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. J Leukoc Biol. 2016;100(6):1239\u201354.","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2020_CR7","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1186\/cc10112","volume":"15","author":"C Guignant","year":"2011","unstructured":"Guignant C, Lepape A, Huang X, Kherouf H, Denis L, Poitevin F, Malcus C, Ch\u00e9ron A, Allaouchiche B, Gueyffier F, et al. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care. 2011;15(2):R99.","journal-title":"Crit Care"},{"issue":"5","key":"2020_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/CCM.0000000000002380","volume":"45","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Fear D, Lavender P, Mare T, Beale R, Swanson C, Singer M, Spencer J. Activation-associated accelerated apoptosis of memory B cells in critically ill patients with sepsis. Crit Care Med. 2017;45(5):875\u201382.","journal-title":"Crit Care Med"},{"issue":"1","key":"2020_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4049\/jimmunol.179.1.13","volume":"179","author":"SG Tangye","year":"2007","unstructured":"Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or \u201cmemory\u201d B cells? J Immunol. 2007;179(1):13\u20139.","journal-title":"J Immunol"},{"issue":"3","key":"2020_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1365-2567.2004.01974.x","volume":"113","author":"A Schiott","year":"2004","unstructured":"Schiott A, Lindstedt M, Johansson-Lindbom B, Roggen E, Borrebaeck CA. CD27- CD4+ memory T cells define a differentiated memory population at both the functional and transcriptional levels. Immunology. 2004;113(3):363\u201370.","journal-title":"Immunology"},{"issue":"5","key":"2020_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/anae.13870","volume":"72","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Rubenfeld GD. The use of enrichment to reduce statistically indeterminate or negative trials in critical care. Anaesthesia. 2017;72(5):560\u20135.","journal-title":"Anaesthesia"},{"issue":"11","key":"2020_CR12","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1097\/CCM.0000000000002627","volume":"45","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Singer M, Spencer J. Can concurrent abnormalities in free light Chains and immunoglobulin concentrations identify a target population for immunoglobulin trials in sepsis? Crit Care Med. 2017;45(11):1829\u201336.","journal-title":"Crit Care Med"},{"issue":"4","key":"2020_CR13","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250\u20136.","journal-title":"Crit Care Med"},{"issue":"12","key":"2020_CR14","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/CCM.0000000000001876","volume":"44","author":"M Shankar-Hari","year":"2016","unstructured":"Shankar-Hari M, Harrison DA, Rowan KM. Differences in impact of definitional elements on mortality precludes international comparisons of sepsis epidemiology-a cohort study illustrating the need for standardized reporting. Crit Care Med. 2016;44(12):2223\u201330.","journal-title":"Crit Care Med"},{"issue":"4","key":"2020_CR15","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/bja\/aex234","volume":"119","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth. 2017;119(4):626\u201336.","journal-title":"Br J Anaesth"},{"issue":"10","key":"2020_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818\u201329.","journal-title":"Crit Care Med"},{"issue":"1","key":"2020_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169653","volume":"12","author":"A Tomino","year":"2017","unstructured":"Tomino A, Tsuda M, Aoki R, Kajita Y, Hashiba M, Terajima T, Kano H, Takeyama N. Increased PD-1 expression and altered T cell repertoire diversity predict mortality in patients with septic shock: a preliminary study. PLoS One. 2017;12(1):e0169653.","journal-title":"PLoS One"},{"issue":"3","key":"2020_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri3802","volume":"15","author":"T Kurosaki","year":"2015","unstructured":"Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol. 2015;15(3):149\u201359.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2020_CR19","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.4049\/jimmunol.175.10.6489","volume":"175","author":"RD Fritsch","year":"2005","unstructured":"Fritsch RD, Shen X, Sims GP, Hathcock KS, Hodes RJ, Lipsky PE. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol. 2005;175(10):6489\u201397.","journal-title":"J Immunol"},{"issue":"3","key":"2020_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva NS, Klein U. Dynamics of B cells in germinal centres. Nat Rev Immunol. 2015;15(3):137\u201348.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2020_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajem.2017.07.002","volume":"36","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Jia Y, Li C, Fang Y, Shao R. The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department. Am J Emerg Med. 2018;36(1):43\u20138.","journal-title":"Am J Emerg Med"},{"issue":"1","key":"2020_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/sji.12509","volume":"85","author":"M Liu","year":"2017","unstructured":"Liu M, Zhang X, Chen H, Wang G, Zhang J, Dong P, Liu Y, An S, Wang L. Serum sPD-L1, upregulated in sepsis, may reflect disease severity and clinical Outcomes in septic patients. Scand J Immunol. 2017;85(1):66\u201372.","journal-title":"Scand J Immunol"},{"issue":"1","key":"2020_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169176","volume":"12","author":"A Lange","year":"2017","unstructured":"Lange A, Sunden-Cullberg J, Magnuson A, Hultgren O. Soluble B and T lymphocyte attenuator correlates to disease severity in sepsis and high levels are associated with an increased risk of mortality. PLoS One. 2017;12(1):e0169176.","journal-title":"PLoS One"},{"issue":"13","key":"2020_CR24","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1084\/jem.20111354","volume":"208","author":"W Xiao","year":"2011","unstructured":"Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581\u201390.","journal-title":"J Exp Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2020-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T19:38:38Z","timestamp":1555443518000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2020-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2020-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"assertion":[{"value":"5 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients who met the eligibility criteria were consented prior to blood sampling. Ethics approval for the study was given by HRA Research Ethics Committee London (Camberwell St Giles) Address: East of England REC Centre Victoria House, Capital Park Fulbourn, Cambridge CB21 5XB. Approval reference: 12\/LO\/0326.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"MS is on the steering committee for a clinical trial of anti PD-L1 therapy in sepsis. The other authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"95"}}